Patient Guide: A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 52 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04300556
Status: 🟢 Enrolling Now
Condition: Solid Tumor
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 52 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Little Rock, Arkansas
  • • Stanford, California
  • • And 49 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types - Join Clinical Trial NCTNCT04300556

How to Join This Clinical Trial - NCTNCT04300556

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Solid Tumor. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Solid Tumor. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Solid Tumor
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04300556 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 52 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85715 - United States

Status: WITHDRAWN

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Stanford, California 94304 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Augusta, Georgia 30912 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Skokie, Illinois 60077 - United States

Status: WITHDRAWN

Clinical Research Site

Louisville, Kentucky 40202 - United States

Status: WITHDRAWN

Clinical Research Site

Baltimore, Maryland 21231 - United States

Status: ACTIVE_NOT_RECRUITING

And 42 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Solid Tumor:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships